Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report)’s share price was down 6.1% during mid-day trading on Tuesday . The company traded as low as $2.74 and last traded at $2.77. Approximately 109,171 shares traded hands during trading, a decline of 92% from the average daily volume of 1,388,685 shares. The stock had previously closed at $2.95.
Hillstream BioPharma Trading Down 6.1 %
The company has a market cap of $48.76 million, a PE ratio of -3.85 and a beta of 3.08. The stock has a fifty day simple moving average of $2.38 and a two-hundred day simple moving average of $2.44.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
See Also
- Five stocks we like better than Hillstream BioPharma
- Investing In Automotive Stocks
- Palantir Cracks $50, Is There Still Time to Get on Board?
- The 3 Best Retail Stocks to Shop for in August
- Insider Buying Signals Upside for These 3 Stocks
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
